ArticleCureus2025
The Relationship Between Multiple Sclerosis and Obesity: A Comparative Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Dysphagia Risk and Its Association with Nutritional Status in Multiple Sclerosis: A Preliminary Study.Nutrients · 2026Article
- Research on metabolic characteristics of multiple sclerosis.Scientific reports · 2026Article
- Is Obesity a Modifiable Risk Factor in Multiple Sclerosis? Mechanistic Insights into Neuroinflammation and Oxidative Damage.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system. It is characterized by inflammation, demyelination, and destruction of the axons. Obesity is a worldwide health issue that involves excessive accumulation of body fat, resulting in negative metabolic and health effects. The association between MS and obesity has received more attention in recent years.
objectivesThe current study aims to evaluate the relationship between MS and obesity and determine whether obesity is a risk factor for MS development, relapse, and disability.
methodsA case-control study was conducted at the Basrah Teaching Hospital MS clinic to compare 80 MS cases with 100 healthy controls, who were age- and sex-matched. Data collected from 1/6/2023 to 1/1/2024 includes sociodemographic factors, clinical characteristics, anthropometric measures, family and childhood obesity history, relapse frequency, and expanded disability status scale scores (EDSS).
resultsThe study compared 80 MS cases with 100 controls. While mean age differed slightly between MS cases (32.34 ± 9.28 years) and controls (30.58 ± 8.67 years), it was not significant (P = 0.196). Female predominance was noted in MS cases (66.3%, n = 53) versus controls (54.0%, n = 54), with no significant difference (P = 0.126). Among the MS cases, the majority exhibit relapsing-remitting MS (RRMS) (73.7%, n = 59), followed by primary progressive MS (PPMS) (16.2%, n = 13), clinically isolated syndrome (CIS) (6.3%, n = 5), and secondary progressive MS (SPMS) (3.8%, n = 3). Childhood obesity was significantly associated with MS development (26.3%, n = 21 in MS cases vs. 1.0%, n = 1 in controls, P = 0.001). Body mass index (BMI) was significantly higher in MS cases (25.04 ± 3.61) than in controls (24.75 ± 3.37, P = 0.016), with a higher proportion of obesity (15.0%, n = 12 in MS cases vs. 5.0%, n = 5 in controls, P = 0.027). A moderate positive correlation existed between BMI and both relapse frequency (r = 0.610) and EDSS scores (r = 0.454), both statistically significant (P = 0.001).
conclusionsThe study found a significant association between increased BMI and MS occurrence, with strong associations to relapse frequency and EDSS scores. Childhood obesity was also linked to MS development, but not a family history of obesity. However, BMI alone may not reliably indicate an MS pattern.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.